Windlas Biotech Ltd Quarterly Results

Gross Sales

187

175.15

171.29

162.21

152.67

Excise Duty

0

0

0

0

0

Net Sales

187

175.15

171.29

162.21

152.67

Other Operating Income

0

0

0

0

0

Other Income

4.84

4.13

4.44

3.16

3.24

Total Income

191.84

179.29

175.73

165.38

155.91

Total Expenditure

163.95

154.27

149.28

141.88

133.99

PBIDT

27.89

25.01

26.45

23.5

21.93

Interest

1.1

0.49

0.28

0.31

0.29

PBDT

26.79

24.52

26.17

23.2

21.64

Depreciation

6.5

6.21

3.54

3.39

3.33

Minority Interest Before NP

0

0

0

0

0

Tax

5.13

4.61

4.55

4.47

4.37

Deferred Tax

-0.5

0.22

1.09

0.24

-0.09

Reported Profit After Tax

15.66

13.48

16.99

15.1

14.03

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

15.66

13.48

16.99

15.1

14.03

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

15.66

13.48

16.99

15.1

14.03

EPS (Unit Curr.)

7.49

6.47

8.17

7.26

6.75

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.45

10.45

10.4

10.4

10.4

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.91

14.27

15.44

14.48

14.36

PBDTM(%)

14.32

13.99

15.27

14.3

14.17

PATM(%)

8.37

7.69

9.91

9.3

9.18